Silexion Therapeutics (SLXNW) Stock Price, News & Analysis
Company Description
Silexion Therapeutics (NASDAQ: SLXNW) is classified in the Biological Products, (no Diagnostic Substances) sector.
SLXNW has declined 60.1% over the past year. Shares last traded at $0.0140.
For FY2025, Silexion Therapeutics reported revenue of $155K with net income of -$11.9M and diluted earnings per share of $89.61. The company operates at a net profit margin of -7685.2%.
This page collects what Stock Titan holds for SLXNW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Silexion Therapeutics (SLXNW) stock last closed at $0.0140. Over the past 12 months, the stock has lost 60.1%.
SLXNW Rankings
Latest News
SEC Filings
Silexion Therapeutics has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form DEF 14A, 1 Form SCHEDULE 13D/A, 1 Form SCHEDULE 13G. The most recent filing was submitted on August 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SLXNW SEC filings →
Financial Highlights
Silexion Therapeutics generated $155K in revenue in FY2025, operating income reached -$11.6M (-7504.5% operating margin), and net income was -$11.9M, reflecting a -7685.2% net profit margin. Diluted earnings per share stood at $89.61. The company generated -$10.8M in operating cash flow. With a current ratio of 2.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Silexion Therapeutics (SLXNW) currently stands at 74.8 thousand shares, down 7.5% from the previous reporting period. Since September 2025, short interest has increased by 1528.2%. The 8.7 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Silexion Therapeutics (SLXNW) currently stands at 8.7 days, up 773% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 773% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 15.0 days.
SLXNW Company Profile & Sector Positioning
Silexion Therapeutics (SLXNW) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.